[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$cmopf
Cosmo Pharma sees strong performance in H1 2025 and launches acne treatment in Singapore and Malaysia. The company is experiencing high social engagement and mentions.
About $cmopf
Cosmo Pharma ($CMOPF) is a healthcare company.
Insights #
- $cmopf engagements is at XXX which is XXX% higher than it's daily average.
- $cmopf creators is at X which is XXX% higher than it's daily average.
- $cmopf creators near a 52-week high at X.
- $cmopf creators is up XXX% from the previous week.
- $cmopf mentions is up XXX% from the previous week.
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XX
1 Month: XXX +171%
1-Year High: XXX on 2025-05-24
1-Year Low: X on 2025-05-02
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: X #
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +100%
1 Month: X +25%
1-Year High: X on 2025-06-13
1-Year Low: X on 2025-04-29
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $cmopf in the last XX hours which is up XXX% from X in the previous XX hours
Daily Average: X
1 Week: X +100%
1 Month: X +100%
1-Year High: X on 2025-07-16
1-Year Low: X on 2025-04-29
Top topics mentioned In the posts about $cmopf in the last XX hours
dermatology, coins ai, quarterly earnings, h1, cosmo, $swdhf, $aclnsw, $dxpto, $dxoto, $rmbhf, otc, investment, coins healthcare, $utgst, $dhs, $totr, $agzd, $tbux
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$CMOPF - Cosmo Delivers Strong Performance in H1 2025 Raises Full-Year EBITDA Guidance and Accelerates Recurring Revenue Growth Across AI and Dermatology -"
@MarcJacksonLA on X 2025-07-23 07:43:40 UTC 7107 followers, XXX engagements
"Cosmo Delivers Strong Performance in H1 2025 Raises Full-Year EBITDA Guidance and Accelerates Recurring Revenue Growth Across AI and Dermatology Full Story: #Cosmo_Pharma $CMOPF #HealthCare #OTC #OTCMarkets #OTCStocks #Investing"
@newsfile_corp on X 2025-07-23 05:10:19 UTC 5185 followers, XX engagements